Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 174
Filter
1.
Hum Exp Toxicol ; 40(12_suppl): S826-S850, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34610256

ABSTRACT

Inorganic arsenic (iAs) exposure is a serious health problem that affects more than 140 million individuals worldwide, mainly, through contaminated drinking water. Acute iAs poisoning produces several symptoms such as nausea, vomiting, abdominal pain, and severe diarrhea, whereas prolonged iAs exposure increased the risk of several malignant disorders such as lung, urinary tract, and skin tumors. Another sensitive endpoint less described of chronic iAs exposure are the non-malignant health effects in hepatic, endocrine, renal, neurological, hematological, immune, and cardiovascular systems. The present review outlines epidemiology evidence and possible molecular mechanisms associated with iAs-toxicity in several non-carcinogenic disorders.


Subject(s)
Arsenic Poisoning/pathology , Arsenic/toxicity , Drinking Water/chemistry , Water Pollutants, Chemical/toxicity , Arsenic/chemistry , Environmental Exposure , Humans , Water Pollutants, Chemical/chemistry
2.
Neurotox Res ; 39(6): 1970-1980, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34533753

ABSTRACT

There is solid epidemiological evidence that arsenic exposure leads to cognitive impairment, while experimental work supports the hypothesis that it also contributes to neurodegeneration. Energy deficit, oxidative stress, demyelination, and defective neurotransmission are demonstrated arsenic effects, but it remains unclear whether synaptic structure is also affected. Employing both a triple-transgenic Alzheimer's disease model and Wistar rats, the cortical microstructure and synapses were analyzed under chronic arsenic exposure. Male animals were studied at 2 and 4 months of age, after exposure to 3 ppm sodium arsenite in drinking water during gestation, lactation, and postnatal development. Through nuclear magnetic resonance, diffusion-weighted images were acquired and anisotropy (integrity; FA) and apparent diffusion coefficient (dispersion degree; ADC) metrics were derived. Postsynaptic density protein and synaptophysin were analyzed by means of immunoblot and immunohistochemistry, while dendritic spine density and morphology of cortical pyramidal neurons were quantified after Golgi staining. A structural reorganization of the cortex was evidenced through high-ADC and low-FA values in the exposed group. Similar changes in synaptic protein levels in the 2 models suggest a decreased synaptic connectivity at 4 months of age. An abnormal dendritic arborization was observed at 4 months of age, after increased spine density at 2 months. These findings demonstrate alterations of cortical synaptic connectivity and microstructure associated to arsenic exposure appearing in young rodents and adults, and these subtle and non-adaptive plastic changes in dendritic spines and in synaptic markers may further progress to the degeneration observed at older ages.


Subject(s)
Arsenic Poisoning/pathology , Cerebral Cortex/drug effects , Synapses/drug effects , Animals , Arsenic Poisoning/diagnostic imaging , Blotting, Western , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/pathology , Diffusion Tensor Imaging , Female , Male , Mice, Transgenic , Neuronal Plasticity/drug effects , Rats , Rats, Wistar , Synapses/pathology
3.
Toxicology ; 457: 152800, 2021 06 15.
Article in English | MEDLINE | ID: mdl-33901604

ABSTRACT

Between 1990 and 2020, our understanding of the significance of arsenic biomethylation changed in remarkable ways. At the beginning of this period, the conversion of inorganic arsenic into mono- and di-methylated metabolites was viewed primarily as a process that altered the kinetic behavior of arsenic. By increasing the rate of clearance of arsenic, the formation of methylated metabolites reduced exposure to this toxin; that is, methylation was detoxification. By 2020, it was clear that at least some of the toxic effects associated with As exposure depended on formation of methylated metabolites containing trivalent arsenic. Because the trivalent oxidation state of arsenic is associated with increased potency as a cytotoxin and clastogen, these findings were consistent with methylation-related changes in the dynamic behavior of arsenic. That is, methylation was activation. Our current understanding of the role of methylation as a modifier of kinetic and dynamic behaviors of arsenic is the product of research at molecular, cellular, organismic, and population levels. This information provides a basis for refining our estimates of risk associated with long term exposure to inorganic arsenic in environmental media, food, and water. This report summarizes the growth of our knowledge of enzymatically catalyzed methylation of arsenic over this period and considers the prospects for new discoveries.


Subject(s)
Arsenic/metabolism , Arsenic/toxicity , Environmental Exposure/adverse effects , Animals , Arsenic Poisoning/metabolism , Arsenic Poisoning/pathology , Humans , Methylation/drug effects , Oxidation-Reduction/drug effects
4.
BMC Pharmacol Toxicol ; 22(1): 19, 2021 04 07.
Article in English | MEDLINE | ID: mdl-33827703

ABSTRACT

BACKGROUND: Arsenic poisoning affects millions of people. The inorganic forms of arsenic are more toxic. Treatment for arsenic poisoning relies on chelation of extracellularly circulating arsenic molecules by 2,3-dimecaptosuccinic acid (DMSA). As a pharmacological intervention, DMSA is unable to chelate arsenic molecules from intracellular spaces. The consequence is continued toxicity and cell damage in the presence of DMSA. A two-pronged approach that removes extracellular arsenic, while protecting from the intracellular arsenic would provide a better pharmacotherapeutic outcome. In this study, Coenzyme Q10 (CoQ10), which has been shown to protect from intracellular organic arsenic, was administered separately or with DMSA; following oral exposure to sodium meta-arsenite (NaAsO2) - a very toxic trivalent form of inorganic arsenic. The aim was to determine if CoQ10 alone or when co-administered with DMSA would nullify arsenite-induced toxicity in mice. METHODS: Group one represented the control; the second group was treated with NaAsO2 (15 mg/kg) daily for 30 days, the third, fourth and fifth groups of mice were given NaAsO2 and treated with 200 mg/kg CoQ10 (30 days) and 50 mg/kg DMSA (5 days) either alone or in combination. RESULTS: Administration of CoQ10 and DMSA resulted in protection from arsenic-induced suppression of RBCs, haematocrit and hemoglobin levels. CoQ10 and DMSA protected from arsenic-induced alteration of WBCs, basophils, neutrophils, monocytes, eosinophils and platelets. Arsenite-induced dyslipidemia was nullified by administration of CoQ10 alone or in combination with DMSA. Arsenite induced a drastic depletion of the liver and brain GSH; that was significantly blocked by CoQ10 and DMSA alone or in combination. Exposure to arsenite resulted in significant elevation of liver and kidney damage markers. The histological analysis of respective organs confirmed arsenic-induced organ damage, which was ameliorated by CoQ10 alone or when co-administered with DMSA. When administered alone, DMSA did not prevent arsenic-driven tissue damage. CONCLUSIONS: Findings from this study demonstrate that CoQ10 and DMSA separately or in a combination, significantly protect against arsenic-driven toxicity in mice. It is evident that with further pre-clinical and clinical studies, an adjunct therapy that incorporates CoQ10 alongside DMSA may find applications in nullifying arsenic-driven toxicity.


Subject(s)
Antidotes/therapeutic use , Arsenic Poisoning/drug therapy , Arsenites/toxicity , Chelating Agents/therapeutic use , Protective Agents/therapeutic use , Sodium Compounds/toxicity , Succimer/therapeutic use , Ubiquinone/analogs & derivatives , Animals , Arsenic Poisoning/blood , Arsenic Poisoning/metabolism , Arsenic Poisoning/pathology , Blood Cells/drug effects , Brain/drug effects , Brain/metabolism , Brain/pathology , Drug Therapy, Combination , Glutathione/metabolism , Hematocrit , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Mice , Ubiquinone/therapeutic use
6.
Am J Dermatopathol ; 43(5): 373-376, 2021 May 01.
Article in English | MEDLINE | ID: mdl-33481374

ABSTRACT

ABSTRACT: Chronic arsenism usually occurs after a long-term unawareness of arsenic exposure from environment, occupation, food, and water. We here reported 3 cases with diffused arsenic keratosis and skin cancers derived from long-term arsenic medication ingestion. In these cases, hyperkeratotic skin lesions were initially found on palms and soles, slowly progressed to every part of the skin and lasted maximally for over 30 years. Skin cancers were diagnosed and removed intermittently within decades, but with no malignancies in other organs. Oral retinoids combing with topical 5- fluorouracil and photodynamic treatment yielded a desirable outcome.


Subject(s)
Arsenic Poisoning/pathology , Iatrogenic Disease , Keratoderma, Palmoplantar/chemically induced , Skin Neoplasms/chemically induced , Aged, 80 and over , Humans , Male , Middle Aged
7.
Ecotoxicol Environ Saf ; 208: 111721, 2021 Jan 15.
Article in English | MEDLINE | ID: mdl-33396052

ABSTRACT

The City of Yellowknife is a known hotspot of arsenic contamination and there is a growing body of evidence suggesting that local wildlife in the vicinity of the abandoned Giant Mine site may be at risk of decreased bone mineralization and various bone disorders. The purpose of this study was to preliminarily measure bone mineral density (BMD) changes and investigate the incidence, pattern, and severity of bone lesions in wild muskrats and red squirrels breeding in three (3) catchment areas at different distances from the Giant Mine Site in Yellowknife, Northwest Territories (Canada): ~2 km (location 1), ~18 km (location 2), and ~40-100 km (location 3). Full femoral bones of 15 muskrats and 15 red squirrels were collected from the three sampling locations (5 from each location) and subjected to radiographic analysis and densitometric measurements. The patterns and severities of bone lesions, including changes in bone mineral density, were evaluated and compared between groups. As levels were significantly higher in the bones of muskrats caught from location 1 and 2, relative to location 3. Further, As and Cd levels were significantly higher in the bones of squirrels caught from locations 1 and 2 relative to squirrels caught from location 3. The preliminary results from bones revealed that radiographic abnormalities such as bone rarefaction, osteopenia, and thinning of the femoral shafts with significant ossific cystic lesions and bowing were the most common skeletal pathologies found in bones of red squirrels from the three locations. Radiographic appearances of massive sclerosis and dysplasia, including severe osteocondensation and osteopathia striata-like abnormalities, were found in the bones of muskrats from all the sampling locations. Densitometric evaluation showed no significant differences between the three locations in the bone parameters measured. However, there was a statistically significant correlation between As content in the bones of muskrats and percent fat content in the femur samples, which suggests that accumulation of As could have been a causal factor for a change in percent fat in femurs of muskrats.


Subject(s)
Arsenic Poisoning/veterinary , Arsenic/adverse effects , Bone Density/drug effects , Bone Diseases/veterinary , Environmental Pollutants/poisoning , Animals , Animals, Wild , Arsenic/metabolism , Arsenic Poisoning/diagnostic imaging , Arsenic Poisoning/pathology , Arvicolinae , Bone Diseases/chemically induced , Bone Diseases/diagnostic imaging , Bone Diseases/pathology , Densitometry , Environmental Pollutants/analysis , Fats/metabolism , Female , Femur/diagnostic imaging , Femur/drug effects , Femur/metabolism , Femur/pathology , Northwest Territories/epidemiology , Sciuridae
8.
Environ Geochem Health ; 43(3): 1165-1175, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32564172

ABSTRACT

Environmental exposure to arsenic is a major public health challenge worldwide. Growing evidence indicates that coal-burning arsenic can cause hepatic oxidative damage. However, the value of Rosa roxburghii Tratt (RRT) with antioxidant properties on arsenic-caused hepatic oxidative damage has never been elucidated yet. In this study, the animals were exposed to coal-burning arsenic (10 mg/kg bw) for 90 days and the result showed a loss of body weight, impaired liver function and liver diseases, increased hepatic oxidative damage and metabolic disorder of multiple elements including selenium, copper, zinc which were related to synthesis of antioxidant enzymes. Another finding is that RRT restored the abnormal liver function and alleviated the procedures of liver diseases of arsenic poisoning rats. In addition, it could also effectively reduce the degree of oxidative damage in serum and liver, and restore the activity of some antioxidant enzymes. Importantly, RRT reversed the content of most disordered elements caused by arsenic in liver and reduced the excretion of several essential elements in urine, including selenium, copper and zinc. Our study provides some limited evidence that RRT can alleviate coal-burning arsenic-induced liver damage induced by regulating elemental metabolic disorders and liver oxidation and antioxidant balance. The study provides a scientific basis for further studies of the causes of the arsenic-induced liver damage, and effective intervention strategies.


Subject(s)
Arsenic Poisoning/pathology , Arsenic/toxicity , Liver/drug effects , Rosa/metabolism , Animals , Antioxidants/metabolism , Arsenic/metabolism , Liver/pathology , Male , Oxidative Stress/drug effects , Rats
9.
Biometals ; 33(6): 379-396, 2020 12.
Article in English | MEDLINE | ID: mdl-33026605

ABSTRACT

Arsenic poisoning is one of the most serious health hazards of recent times. It has been estimated that more than 200 million people of about 105 countries in the world are affected due to arsenic poisoning. Except mitigation, there is no such mode by which the population can be prevented from being exposed to arsenic. Tinospora cordifolia (T. cordifolia) is widely used in the folk medicine system for the treatment of various diseases. Hence, the aim of the present study was to investigate the antidote effects of ethanolic extract of T. cordifolia stem against arsenic induced hepato-renal toxicity in rat model. Twenty-four male Charles Foster rats (weighing 160-180 g) were randomly divided into two groups, where six rats were used as control group. Eighteen rats were orally treated with arsenic at the dose of 8 mg/kg body weight for 90 days daily and then further divided into three sub groups (n = 6 each). Sub group I-arsenic treated rats, were sacrificed after treatment; sub group II rats were used as arsenic control and the sub group III rats were administrated with T. cordifolia at the dose of 400 mg/kg body weight/day for 90 days. After the completion of dose duration, all the control and treatment group rats were sacrificed to evaluate the various parameters. Arsenic induced rats had significantly (p < 0.0001) altered biochemical serum levels of SGPT, SGOT, ALP, total bilirubin, urea, uric acid, creatinine and albumin; But, after the administration of T. cordifolia there was significant (p < 0.0001) restoration observed in these liver and kidney function parameters. The T. cordifolia administration also significantly (p < 0.0001) restored the serum MDA levels and arsenic concentration in blood, liver and kidney tissues, as well as significant (p < 0.0001) improvement in haematological variables. In histopathological study, the arsenic treated rats showed degenerative changes in the liver and kidney tissues such as lesions and vacuolizations in hepatocytes and nephrocytes respectively. However, after the administration with T. cordifolia rats, there was considerably significant restoration in liver and kidney tissues. The entire study suggests that arsenic caused severe damage to the liver and kidney at haematological, biochemical and histopathological levels in rats. However, T. cordifolia played the vital role to combat the arsenic induced toxicity in rats. Hence, T. cordifolia might be used as a nutritional supplement to combat the arsenic led toxicity among the exposed population.


Subject(s)
Arsenic Poisoning/drug therapy , Phytochemicals/pharmacology , Tinospora/chemistry , Administration, Oral , Animals , Arsenic/administration & dosage , Arsenic/toxicity , Arsenic Poisoning/pathology , Disease Models, Animal , Dose-Response Relationship, Drug , Environmental Monitoring , Hepatocytes/drug effects , Hepatocytes/pathology , Male , Phytochemicals/administration & dosage , Phytochemicals/chemistry , Podocytes/drug effects , Podocytes/pathology , Rats , Rats, Inbred Strains
10.
Toxicol Appl Pharmacol ; 407: 115251, 2020 11 15.
Article in English | MEDLINE | ID: mdl-32980394

ABSTRACT

Acute exposure to arsenic is known to cause bone marrow depression and result in anemia, in which the dusfunction of cells in the bone marrow niche such as mesenchymal stem cells (MSCs) is vital. However, the mechanism underlying response of MSCs to arsenic challange is not fully understood. In the present study, we investigated the role of nuclear factor erythroid 2-related factor (NRF) 1 (NRF1), a sister member of the well-known master regulator in antioxidative response NRF2, in arsenite-induced cytotoxicity in mouse bone marrow-derived MSCs (mBM-MSCs). We found that arsenite exposure induced significant increase in the protein level of long-isoform NRF1 (L-NRF1). Though short-isoform NRF1 (S-NRF1) was induced by arsenite at mRNA level, its protein level was not obviously altered. Silencing L-Nrf1 sensitized the cells to arsenite-induced cytotoxicity. L-Nrf1-silenced mBM-MSCs showed decreased arsenic efflux with reduced expression of arsenic transporter ATP-binding cassette subfamily C member 4 (ABCC4), as well as compromised NRF2-mediated antioxidative defense with elevated level of mitochondrial reactive oxygen species (mtROS) under arsenite-exposed conditions. A specific mtROS scavenger (Mito-quinone) alleviated cell apoptosis induced by arsenite in L-Nrf1-silenced mBM-MSCs. Taken together, these findings suggest that L-NRF1 protects mBM-MSCs from arsenite-induced cytotoxicity via suppressing mtROS in addition to facilitating cellular arsenic efflux.


Subject(s)
Arsenic Poisoning/pathology , Arsenic/metabolism , Bone Marrow Cells/pathology , Mesenchymal Stem Cells/pathology , Mitochondria/metabolism , NF-E2-Related Factor 1/metabolism , Reactive Oxygen Species/metabolism , Animals , Apoptosis/drug effects , Bone Marrow Cells/drug effects , Gene Silencing , Male , Mesenchymal Stem Cells/drug effects , Mice , Mice, Inbred C57BL , Multidrug Resistance-Associated Proteins/metabolism , NF-E2-Related Factor 1/biosynthesis , NF-E2-Related Factor 1/genetics , Organophosphorus Compounds/pharmacology , Oxidative Stress/drug effects , RNA, Messenger/biosynthesis , Ubiquinone/analogs & derivatives , Ubiquinone/pharmacology
11.
Cancer Sci ; 111(10): 3873-3880, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32885537

ABSTRACT

In 1955, an outbreak of arsenic poisoning caused by the ingestion of arsenic-contaminated Morinaga Dry Milk occurred in western Japan. This study aimed to assess the mortality and cancer incidence risk among Japanese individuals who were poisoned during this time as infants. In total, 6223 survivors (mean age at enrollment, 27.5 y) who had ingested contaminated milk when they were aged ≤ 2 y participated in this study. Follow-up was conducted from 1982 to 2018 (mean follow-up duration, 30.3 y). Standardized mortality ratio (SMR) and standardized incidence ratio (SIR) were used to compare mortality and cancer incidence rates of subjects with the respective Japanese population rates, and 95% confidence intervals (95% CIs) of the SMR and SIR were also calculated. In total, 561 deaths and 524 new cancer cases were observed. A statistically significant increase in mortality rate was observed for all causes (SMR, 1.15; 1.01-1.19), nervous system disease (2.83, 1.62-4.19), respiratory disease (2.02, 1.37-2.62), genitourinary system disease (2.25, 1.10-3.73), and traffic accident (2.03, 1.14-3.04). In contrast, a significant decrease in cancer incidence rate was observed for all cancers (SIR, 0.96; 0.84-0.99), stomach cancer (0.77, 0.57-0.92), colon cancer (0.63, 0.41-0.85), rectum cancer (0.69, 0.43-0.95), and breast cancer (0.72, 0.52-0.89). Liver cancer showed a high mortality rate (SMR, 1.68; 1.06-2.31). In this study, after the long-term follow-up we revealed overall and cause-specific mortality and cancer incidence risk among survivors who ingested arsenic-contaminated dry milk as infants.


Subject(s)
Arsenic Poisoning/mortality , Liver Neoplasms/mortality , Milk/adverse effects , Powders/adverse effects , Adult , Animals , Arsenic Poisoning/pathology , Breast Neoplasms/chemically induced , Breast Neoplasms/mortality , Colonic Neoplasms/chemically induced , Colonic Neoplasms/mortality , Female , Humans , Infant , Liver Neoplasms/chemically induced , Male , Middle Aged , Rectal Neoplasms/chemically induced , Rectal Neoplasms/mortality , Risk , Stomach Neoplasms/chemically induced , Stomach Neoplasms/mortality , Survivors
12.
J Appl Toxicol ; 40(12): 1661-1672, 2020 12.
Article in English | MEDLINE | ID: mdl-32608101

ABSTRACT

Long-term arsenic exposure is a worldwide public health problem that causes serious harm to human health. The liver is the main target organ of arsenic toxicity; arsenic induces disruption of the DNA damage repair pathway, but its mechanisms remain unclear. In recent years, studies have found that epigenetic mechanisms play an important role in arsenic-induced lesions. In this study, we conducted experiments in vitro using normal human liver cells (L-02) to explore the mechanism by which the histone demethylase JHDM2A regulates H3K9 dimethylation (me2) in response to arsenic-induced DNA damage. Our results indicated that arsenic exposure upregulated the expression of JHDM2A, downregulated global H3K9me2 modification levels, increased the H3K9me2 levels at the promoters of base excision repair (BER) genes (N-methylpurine-DNA glycosylase [MPG], XRCC1 and poly(ADP-ribose)polymerase 1) and inhibited their expression levels, causing DNA damage in cells. In addition, we studied the effects of overexpression and inhibition of JHDM2A and found that JHDM2A can participate in the molecular mechanism of arsenic-induced DNA damage via the BER pathway, which may not be involved in the BER process because H3K9me2 levels at the promoter region of the BER genes were unchanged following JHDM2A interference. These results suggest a potential mechanism by which JHDM2A can regulate the MPG and XRCC1 genes in the process of responding to DNA damage induced by arsenic exposure and can participate in the process of DNA damage repair, which provides a scientific basis for understanding the epigenetic mechanisms and treatments for endemic arsenic poisoning.


Subject(s)
Arsenic Poisoning/etiology , Arsenites/toxicity , Chemical and Drug Induced Liver Injury/etiology , DNA Damage , DNA Repair , Histones/metabolism , Jumonji Domain-Containing Histone Demethylases/metabolism , Liver/drug effects , Sodium Compounds/toxicity , Arsenic Poisoning/enzymology , Arsenic Poisoning/genetics , Arsenic Poisoning/pathology , Cell Line , Chemical and Drug Induced Liver Injury/enzymology , Chemical and Drug Induced Liver Injury/genetics , Chemical and Drug Induced Liver Injury/pathology , DNA Glycosylases/genetics , DNA Glycosylases/metabolism , Humans , Jumonji Domain-Containing Histone Demethylases/genetics , Liver/enzymology , Liver/pathology , Methylation , Poly (ADP-Ribose) Polymerase-1/genetics , Poly (ADP-Ribose) Polymerase-1/metabolism , Promoter Regions, Genetic , X-ray Repair Cross Complementing Protein 1/genetics , X-ray Repair Cross Complementing Protein 1/metabolism
13.
Ecotoxicol Environ Saf ; 200: 110742, 2020 Sep 01.
Article in English | MEDLINE | ID: mdl-32470681

ABSTRACT

The accumulation of arsenic in rice has become a worldwide concern. In this study, dose-dependency in tissues (intestine, liver and kidney) and blood distribution of inorganic arsenicals and their methylated metabolites were investigated in male C57BL/6 mice exposed to four arsenic species (arsenite [iAs]III, arsenate [iAs]V, monomethylarsonate [MMA]V, and dimethylarsinate [DMA]V) at four doses (control [C]: 0 µg/g, simulation [S]: 0.91 µg/g, medium [M]: 9.1 µg/g and high [H]: 30 µg/g) according to the arsenical composition in rice for 8 and 16 weeks. No adverse effects were observed, while body weight gain decreased in group H. Increases in total arsenic concentrations (CtAs) and histopathological changes in the tissues occurred in all of the test groups. CtAs presented a tendency of kidney > intestine > liver > blood and were time-/dose-dependent in the liver and kidney in groups M and H. In the intestine and blood, abundant iAs (23%-28% in blood and 36%-49% in intestine) was detected in groups M and H, and CtAs decreased in group H from the 8th week to the 16th week. PMI decreased in the liver and SMI decreased in the kidney. These results indicate that the three tissues are injured through food arsenic. The intestine can also accumulate food arsenic, and the high arsenic dose will cause a deficiency in the absorbing function of the intestine. Thus, long-term exposure to arsenic-contaminated rice should be taken seriously attention.


Subject(s)
Arsenic Poisoning , Arsenicals/pharmacokinetics , Animals , Arsenates/pharmacokinetics , Arsenates/toxicity , Arsenic Poisoning/metabolism , Arsenic Poisoning/pathology , Arsenites/pharmacokinetics , Arsenites/toxicity , Cacodylic Acid/pharmacokinetics , Cacodylic Acid/toxicity , Dietary Exposure , Intestines/drug effects , Intestines/pathology , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Inbred C57BL , Oryza/metabolism
14.
Toxicol Appl Pharmacol ; 393: 114955, 2020 04 15.
Article in English | MEDLINE | ID: mdl-32171569

ABSTRACT

Inorganic arsenic is among the major contaminants of groundwater in the world. Worldwide population-based studies demonstrate that chronic arsenic exposure is associated with poor cognitive performance among children and adults, while research in animal models confirms learning and memory deficits after arsenic exposure. The aim of this study was to investigate the long-term effects of environmentally relevant arsenic exposure in the myelination process of the prefrontal cortex (PFC) and corpus callosum (CC). A longitudinal study with repeated follow-up assessments was performed in male Wistar rats exposed to 3 ppm sodium arsenite in drinking water. Animals received the treatment from gestation until 2, 4, 6, or 12 months of postnatal age. The levels of myelin basic protein (MBP) were evaluated by immunohistochemistry/histology and immunoblotting from the PFC and CC. As plausible alterations associated with demyelination, we considered mitochondrial mass (VDAC) and two axonal damage markers: amyloid precursor protein (APP) level and phosphorylated neurofilaments. To analyze the microstructure of the CC in vivo, we acquired diffusion-weighted images at the same ages, from which we derived metrics using the tensor model. Significantly decreased levels of MBP were found in both regions together with significant increases of mitochondrial mass and slight axonal damage at 12 months in the PFC. Ultrastructural imaging demonstrated arsenic-associated decreases of white matter volume, water diffusion anisotropy, and increases in radial diffusivity. This study indicates that arsenic exposure is associated with a significant and persistent negative impact on microstructural features of white matter tracts.


Subject(s)
Arsenic Poisoning/pathology , Demyelinating Diseases/pathology , Aging , Amyloid beta-Protein Precursor/metabolism , Animals , Arsenic Poisoning/diagnostic imaging , Arsenites/toxicity , Axons/pathology , Corpus Callosum/pathology , Demyelinating Diseases/diagnostic imaging , Diffusion Tensor Imaging , Drinking Water , Immunohistochemistry , Male , Mitochondria/drug effects , Mitochondria/metabolism , Myelin Basic Protein/metabolism , Neurofilament Proteins/metabolism , Prefrontal Cortex/pathology , Rats , Rats, Wistar , Sodium Compounds/toxicity , White Matter/diagnostic imaging , White Matter/pathology
16.
Sci Rep ; 9(1): 11240, 2019 08 02.
Article in English | MEDLINE | ID: mdl-31375744

ABSTRACT

Arsenic poisoning has been a major concern that causes severe toxicological damages. Therefore, intricate and inclusive understanding of arsenic flux rates is required to ascertain the cellular concentration and establish the carcinogenetic mechanism of this toxicant at real time. The lack of sufficiently sensitive sensing systems has hampered research in this area. In this study, we constructed a fluorescent resonance energy transfer (FRET)-based nanosensor, named SenALiB (Sensor for Arsenic Linked Blackfoot disease) which contains a metalloregulatory arsenic-binding protein (ArsR) as the As3+ sensing element inserted between the FRET pair enhanced cyan fluorescent protein (ECFP) and Venus. SenALiB takes advantage of the ratiometic FRET readout which measures arsenic with high specificity and selectivity. SenALiB offers rapid detection response, is stable to pH changes and provides highly accurate, real-time optical readout in cell-based assays. SenALiB-676n with a binding constant (Kd) of 0.676 × 10-6 M is the most efficient affinity mutant and can be a versatile tool for dynamic measurement of arsenic concentration in both prokaryotes and eukaryotes in vivo in a non-invasive manner.


Subject(s)
Arsenic/metabolism , Biosensing Techniques/instrumentation , Fluorescence Resonance Energy Transfer/instrumentation , Intravital Microscopy/instrumentation , Nanostructures/chemistry , Arsenic/analysis , Arsenic/toxicity , Arsenic Poisoning/pathology , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Biosensing Techniques/methods , Fluorescence Resonance Energy Transfer/methods , Fluorescent Dyes/chemistry , Green Fluorescent Proteins/chemistry , Green Fluorescent Proteins/genetics , HEK293 Cells , Humans , Intravital Microscopy/methods , Luminescent Proteins/chemistry , Luminescent Proteins/genetics , Microscopy, Fluorescence/instrumentation , Microscopy, Fluorescence/methods , Mutagenesis, Site-Directed , Mutation , Sensitivity and Specificity
17.
Metallomics ; 11(8): 1411-1418, 2019 08 01.
Article in English | MEDLINE | ID: mdl-31313790

ABSTRACT

Inorganic arsenic (As) is the most toxic form of As found in food and water. Gastrointestinal disorders have been reported in populations chronically exposed to this arsenical form or to one of its metabolites; however, studies to determine the mechanisms of inorganic As toxicity at the intestinal level are scarce. The aim of this study is to determine the mechanisms of toxicity of inorganic As [As(iii) and As(v)] on intestinal epithelial cells. For this purpose, two human intestinal cell models were used: non-transformed colon epithelial cells (NCM460) and epithelial cells from a colorectal adenocarcinoma (Caco-2). Exposure to As(iii) and As(v) generates an increase in the release of the pro-inflammatory cytokine IL-8 (57-1135%) and an increase in the generation of reactive oxygen and/or nitrogen species (130-340%) in both cell lines. This pro-inflammatory and pro-oxidant response may be responsible for the structural and functional modifications demonstrated in the monolayers formed by both cell types. Treatments with As(iii) and As(v) produce a redistribution of zonula occludens 1 and a reduction in the expression of claudin 1, tight junction proteins that participate in maintaining the structure of the epithelium. All these toxic effects are finally translated into a loss of the barrier function of intestinal monolayers.


Subject(s)
Arsenic/toxicity , Intestinal Mucosa/drug effects , Arsenic Poisoning/etiology , Arsenic Poisoning/immunology , Arsenic Poisoning/pathology , Caco-2 Cells , Cell Line , Humans , Inflammation/chemically induced , Inflammation/immunology , Inflammation/pathology , Interleukin-8/immunology , Intestinal Mucosa/immunology , Intestinal Mucosa/pathology , Reactive Oxygen Species/immunology
19.
Forensic Sci Int ; 300: e24-e30, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31023496

ABSTRACT

Realgar (arsenic sulfide) is widely used in combination with other herbs as Chinese patent medicine to treat a variety of diseases in China. As a mineral arsenic, its mild toxicity was also well known. Longtime over-dose usage or wrongly oral intake of realgar can cause chronic arsenic poisoning and/or death, but acute fatal arsenic poisoning resulted from short-term dermal use of realgar-containing medicine was very rare. Here, we present the case of a 35-year-old Chinese man, who was diagnosed with severe psoriasis and died of fatal acute arsenic poisoning after he applied a local folk prescription ointment containing mainly the realgar to the affected skin for about 4 days. The autopsy showed multiple punctate hemorrhages over the limbs, pleural effusion, edematous lungs with consolidation, mild myocardial hypertrophy and normal-looking kidneys. The histopathological examination of renal tissue showed severe degeneration, necrosis and desquamation of renal tubular epithelial cells, presence of protein cast and a widened edematous interstitium with interstitial fibrosis. The presence of arsenic in large amount in the ointment (about 6%), in blood (1.76 µg/mL), and in skin (4.71 µg/g), were confirmed analytically. We also provide the clinical records of the deceased and briefly reviewed 7 similar cases in literature (6 in Chinese and 1 in English) in the past 30 years in China.


Subject(s)
Arsenic Poisoning/etiology , Medicine, Chinese Traditional/adverse effects , Sulfides/poisoning , Administration, Topical , Adult , Arsenic Poisoning/pathology , Arsenicals/administration & dosage , Arsenicals/analysis , China , Hemorrhage/pathology , Humans , Kidney/pathology , Lung/pathology , Male , Ointments , Pleural Effusion/pathology , Skin/chemistry , Sulfides/administration & dosage , Sulfides/analysis
20.
Clin Dermatol ; 37(2): 136-147, 2019.
Article in English | MEDLINE | ID: mdl-30981294

ABSTRACT

Dermatology is frequently viewed by physician and surgical colleagues as a specialty with few emergencies. Although the majority of dermatology practice is in the office setting, cutaneous emergencies do occur through referrals from primary care and as ward consults. Even though cutaneous signs of poisoning would be an uncommon emergency consultation, it is important for dermatologists to be aware of the clinical presentations so as to be able instigate appropriate time critical treatments.


Subject(s)
Arsenic Poisoning/complications , Arsenic Poisoning/pathology , Carbon Monoxide Poisoning/complications , Carbon Monoxide Poisoning/pathology , Dioxins/poisoning , Exanthema/etiology , Exanthema/pathology , Mercury Poisoning/complications , Mercury Poisoning/pathology , Skin/pathology , Acute Disease , Agent Orange/poisoning , Chronic Disease , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...